Pages that link to "Q36695683"

The following pages link to The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer (Q36695683):

Displaying 26 items.

• C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review (Q26771557) (← links)
• Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. (Q34079559) (← links)
• Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients (Q34408625) (← links)
• Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma (Q35115559) (← links)
• The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer (Q35551037) (← links)
• The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer (Q35954348) (← links)
• Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy (Q36148206) (← links)
• Genomics of renal cell cancer-- does it provide breakthrough? (Q36428987) (← links)
• Treatment for renal cancer: are we beyond the cytokine era? (Q36590472) (← links)
• The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer (Q36612383) (← links)
• Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. (Q36613902) (← links)
• The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer (Q36614384) (← links)
• The role of the systemic inflammatory response as a biomarker in immunotherapy for renal cell cancer (Q37605784) (← links)
• Role of C-reactive protein as a biomarker for renal cell carcinoma (Q37812611) (← links)
• C-reactive protein as a biomarker for urological cancers (Q37949270) (← links)
• Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes (Q38035035) (← links)
• C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation (Q42590411) (← links)
• Prognostic factors in patients with gemcitabine-refractory pancreatic cancer (Q45233598) (← links)
• Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial (Q45543729) (← links)
• Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer (Q47142109) (← links)
• Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors (Q50876563) (← links)
• Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. (Q54491390) (← links)
• Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer (Q79409152) (← links)
• Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment (Q89080538) (← links)
• Sarcopenia predicts prognosis of patients with renal cell carcinoma: A systematic review and meta-analysis (Q90657636) (← links)
• Predictive impact of an early change in serum C-reactive protein levels in nivolumab therapy for metastatic renal cell carcinoma (Q92176242) (← links)